Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation

dc.contributor.authorBatalha, V. L.por
dc.contributor.authorPêgo, José M.por
dc.contributor.authorFontinha, B. M.por
dc.contributor.authorCostenla, A. R.por
dc.contributor.authorValadas, J. S.por
dc.contributor.authorBaqi, Y.por
dc.contributor.authorRadjainia, H.por
dc.contributor.authorMüller, C. E.por
dc.contributor.authorSebastião, A. M.por
dc.contributor.authorLopes, L. V.por
dc.date.accessioned2015-02-09T15:48:11Z
dc.date.available2015-02-09T15:48:11Z
dc.date.issued2013
dc.date.updated2015-02-09T12:11:23Z
dc.description.abstractMaternal separation (MS) is an early life stress model that induces permanent changes in the central nervous system, impairing hippocampal long-term potentiation (LTP) and spatial working memory. There are compelling evidences for a role of hippocampal adenosine A(2A) receptors in stress-induced modifications related to cognition, thus opening a potential window for therapeutic intervention. Here, we submitted rats to MS and evaluated the long-lasting molecular, electrophysiological and behavioral impairments in adulthood. We then assessed the therapeutic potential of KW6002, a blocker of A(2A) receptors, in stress-impaired animals. We report that the blockade of A(2A) receptors was efficient in reverting the behavior, electrophysiological and morphological impairments induced by MS. In addition, this effect is associated with restoration of the hypothalamic-pituitary-adrenal axis (HPA-axis) activity, as both the plasma corticosterone levels and hippocampal glucocorticoid receptor expression pattern returned to physiological-like status after the treatment. These results reveal the involvement of A(2A) receptors in the stress-associated impairments and directly in the stress response system by showing that the dysfunction of the HPA-axis as well as the long-lasting synaptic and behavioral effects of MS can be reverted by targeting adenosine A(2A) receptors. These findings provide a novel evidence for the use of adenosine A(2A) receptor antagonists as potential therapy against psychopathologiespor
dc.description.sponsorshipWe acknowledge Alexandre de Mendonca, David Blum and Rodrigo Cunha for helpful discussions. VLB is thankful to Joao Baiao and Carla Batalha for technical assistance. VLB has been awarded a PhD fellowship from Fundacao para a Ciencia e Tecnologia (BD/63041/2009). LVL is funded by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-NEU/099853/2008) and by EU programme Egide-Pessoa. YB and CEM were funded by the Ministry for Education and Research (BMBF, Grant number 01EW0911) in the frame of ERA-NET NEURON.por
dc.identifier.doi10.1038/mp.2012.8por
dc.identifier.issn1359-4184por
dc.identifier.pmid22371048por
dc.identifier.urihttps://hdl.handle.net/1822/33735
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherNature Publishing Grouppor
dc.relation.publisherversionhttp://www.nature.com/mp/journal/v18/n3/full/mp20128a.htmlpor
dc.rightsopenAccesspor
dc.subjectAdenosine A2A receptorspor
dc.subjectCorticosteronepor
dc.subjectHippocampuspor
dc.subjectHPA-axispor
dc.subjectMaternal separationpor
dc.subjectStresspor
dc.subjectadenosine A receptors 2Apor
dc.subject.wosScience & Technologypor
dc.titleAdenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillationpor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationEndPage12por
oaire.citationIssue3por
oaire.citationStartPage1por
oaire.citationTitleMolecular Psychiatrypor
oaire.citationVolume18por
sdum.journalMolecular Psychiatrypor
sdum.publicationstatuspublishedpor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
batalha vl_mol psychiatry 2013 posp.pdf
Tamanho:
751 KB
Formato:
Adobe Portable Document Format